CGIM
EPIX

Cannon Global Investment Management’s ESSA Pharma EPIX Stock Holding History

Cannon Global Investment Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,300
Closed -$95K – 20
2022
Q1 		$95K Buy
+15,300
New +$135K 0.07% 98

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Cannon Global Investment Management's EPIX Position: Q2 2022 in Review

Cannon Global Investment Management sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 15,300 shares — an estimated $95K sold.

Cannon Global Investment Management first reported a position in EPIX in Q1 2022 and held it in 1 quarter. The position peaked at $95K in Q1 2022. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

  • Cannon Global Investment Management reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
  • Cannon Global Investment Management sold 15,300 ESSA Pharma shares in Q2 2022, an estimated $95K.
  • Cannon Global Investment Management first reported a position in ESSA Pharma in Q1 2022 and held it in 1 quarter.
  • Cannon Global Investment Management's ESSA Pharma position peaked at $95K in Q1 2022.
  • 59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Cannon Global Investment Management's 13F filing for Q2 2022, filed 4 Aug 2022.